{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:16:57Z","timestamp":1757614617408,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"DOI":"10.7759\/cureus.91646","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:29:16Z","timestamp":1757064556000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving Safe Initiation of Direct Oral Anticoagulant Therapy: A Two-Cycle Quality Improvement Project"],"prefix":"10.7759","author":[{"given":"Orzo","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honey","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwe","family":"San","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-32. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly SJ","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, et al.. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009, 361:1139-51. 10.1056\/NEJMoa0905561","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb M","year":"2013","unstructured":"Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis. 2013, 35:312-9. 10.1007\/s11239-013-0899-7","journal-title":"J Thromb Thrombolysis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-021-03212-y","article-title":"Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis","volume":"78","author":"Al Rowily A","year":"2022","unstructured":"Al Rowily A, Jalal Z, Price MJ, Abutaleb MH, Almodiaemgh H, Al Ammari M, Paudyal V. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2022, 78:623-45. 10.1007\/s00228-021-03212-y","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002298","article-title":"Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System","volume":"28","author":"Mulac A","year":"2021","unstructured":"Mulac A, Taxis K, Hagesaether E, Gerd Granas A. Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System. Eur J Hosp Pharm. 2021, 28:e56-61. 10.1136\/ejhpharm-2020-002298","journal-title":"Eur J Hosp Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-023-00563-y","article-title":"Patients' views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study","volume":"16","author":"Al Rowily A","year":"2023","unstructured":"Al Rowily A, Baraka MA, Abutaleb MH, Alhayyan AM, Aloudah N, Jalal Z, Paudyal V. Patients' views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study. J Pharm Policy Pract. 2023, 16:58. 10.1186\/s40545-023-00563-y","journal-title":"J Pharm Policy Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/10742484211019657","article-title":"Prescribing errors with direct oral anticoagulants and their impact on the risk of bleeding in patients with atrial fibrillation","volume":"26","author":"Raccah BH","year":"2021","unstructured":"Raccah BH, Erlichman Y, Pollak A, Matok I, Muszkat M. Prescribing errors with direct oral anticoagulants and their impact on the risk of bleeding in patients with atrial fibrillation. J Cardiovasc Pharmacol Ther. 2021, 26:601-10. 10.1177\/10742484211019657","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.06.009","article-title":"Anticoagulation-associated adverse drug events","volume":"124","author":"Piazza G","year":"2011","unstructured":"Piazza G, Nguyen TN, Cios D, et al.. Anticoagulation-associated adverse drug events. Am J Med. 2011, 124:1136-42. 10.1016\/j.amjmed.2011.06.009","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56004","article-title":"A quality improvement initiative to reduce prescription error in a pediatrics outpatient department at a secondary-level community hospital","volume":"16","author":"Gupta A","year":"2024","unstructured":"Gupta A, Malhotra S, Mandal S, Ahmad A, Polisetty V, Shaik DN, Deorari AK. A quality improvement initiative to reduce prescription error in a pediatrics outpatient department at a secondary-level community hospital. Cureus. 2024, 16:e56004. 10.7759\/cureus.56004","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.02.015","article-title":"Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: a quality improvement initiative","volume":"236","author":"Simard C","year":"2024","unstructured":"Simard C, Poirier-Blanchette L, Rizzolo A, Cafaro T, Kerzner R, Mantzanis H, Koolian M. Standardized direct oral anticoagulants prescription for treatment of acute venous thromboembolism in the emergency department: a quality improvement initiative. Thromb Res. 2024, 236:68-73. 10.1016\/j.thromres.2024.02.015","journal-title":"Thromb Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407456-improving-safe-initiation-of-direct-oral-anticoagulant-therapy-a-two-cycle-quality-improvement-project","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:29:17Z","timestamp":1757064557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407456-improving-safe-initiation-of-direct-oral-anticoagulant-therapy-a-two-cycle-quality-improvement-project"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.91646","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}